HER2-targeted therapy refers to a range of treatments specifically designed to target the HER2 protein. These therapies aim to inhibit the activity of HER2, thereby slowing down or stopping the growth of cancer cells. This can be achieved through monoclonal antibodies, tyrosine kinase inhibitors, or antibody-drug conjugates.
